IFP Advisors, Inc - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 194 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$177
-46.7%
25
-50.0%
0.00%
Q2 2023$332
+104.9%
50
+92.3%
0.00%
Q1 2023$162
+362.9%
26
-99.5%
0.00%
-100.0%
Q4 2022$35
-99.9%
5,543
-3.6%
0.00%0.0%
Q3 2022$36,0000.0%5,7510.0%0.00%0.0%
Q2 2022$36,000
-2.7%
5,751
-1.3%
0.00%
Q1 2022$37,000
+3600.0%
5,829
+7373.1%
0.00%
Q4 2021$1,000
-85.7%
78
-85.5%
0.00%
Q3 2021$7,000
-95.0%
538
-93.9%
0.00%
-100.0%
Q2 2021$140,000
+122.2%
8,822
+44.6%
0.00%
+200.0%
Q1 2021$63,000
+14.5%
6,099
-16.4%
0.00%
-50.0%
Q4 2020$55,000
+685.7%
7,295
+231.6%
0.00%
Q3 2020$7,0002,2000.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$0
-100.0%
0
-100.0%
0.00%
Q3 2017$5,000
-16.7%
1,0000.0%0.00%
Q2 2017$6,000
-25.0%
1,0000.0%0.00%
Q1 2017$8,000
+33.3%
1,0000.0%0.00%
Q4 2016$6,000
+50.0%
1,0000.0%0.00%
Q3 2016$4,000
+33.3%
1,0000.0%0.00%
Q2 2016$3,000
-70.0%
1,0000.0%0.00%
-100.0%
Q4 2015$10,0001,0000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Burrage Capital Management LLC 1,105,673$8,237,0006.28%
Sarissa Capital Management LP 8,175,000$60,903,0006.22%
ORACLE INVESTMENT MANAGEMENT INC 2,980,870$22,207,0002.78%
DG Capital Management, LLC 1,075,732$8,014,0001.70%
Ghost Tree Capital, LLC 900,000$6,705,0001.49%
Parkman Healthcare Partners LLC 538,370$4,011,0001.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,835,810$43,477,0000.86%
Formidable Asset Management, LLC 470,419$3,470,0000.80%
KNOTT DAVID M 219,461$1,635,0000.74%
Altium Capital Management LP 250,000$1,863,0000.70%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders